Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS
慢性阻塞性肺疾病(COPD)患者开始使用含超细倍氯米松二丙酸酯的固定剂量吸入性糖皮质激素(ICS)/长效支气管扩张剂(LABD)制剂与开始使用不含ICS的LABD相比,发生肺炎的风险比较。
期刊:
影响因子:
doi:10.2147/POR.S438031
Price, David; Henley, William; Cançado, José Eduardo Delfini; Fabbri, Leonardo M; Kerstjens, Huib A M; Papi, Alberto; Roche, Nicolas; Şen, Elif; Singh, Dave; Vogelmeier, Claus F; Nudo, Elena; Carter, Victoria; Skinner, Derek; Vella, Rebecca; Soriano, Joan B; Kots, Maxim; Georges, George